New York · 2025 Regular Session · Bill
A 11628: Requires insurance coverage for FDA approved expanded access to certain investigational medical products
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 11628 is a bill introduced in the New York House on July 29, 2026. According to its official title, it concerns: Requires insurance coverage for FDA approved expanded access to certain investigational medical products. Primary sponsor: Rules Committee. Most recent recorded action (July 29, 2026): REFERRED TO INSURANCE.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires insurance policies to provide coverage for federal food and drug administration approved expanded access to an investigational medical product that has been shown to be effective, without the need for any prior authorization determination.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Rules Committee | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO INSURANCE